Evan Kennedy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Evan Kennedy has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Hayley Born
Department of Otolaryngology-Head and Neck Surgery, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York
2 shared publications - Isaac L. Alter
Department of Otolaryngology—Head and Neck Surgery, Columbia University Vagelos College of Physicians and Surgeons New York‐Presbyterian/Columbia University Irving Medical Center New York New York USA
2 shared publications - Ryan C. Branski
Rehabilitation Medicine NYU Grossman School of Medicine New York New York U.S.A.
2 shared publications - Can Doruk
Department of Otolaryngology & Head and Neck Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
1 shared publication Carly Schiff
1 shared publication- Catherine Gbekie
Columbia University Vagelos College of Physicians and Surgeons
1 shared publication
Latest Publications
- 27 August 2026
- Published by Elsevier in Journal of Voice
Practice Patterns of Speech-Language Pathologists for Vocal Fold Paresis
- 27 August 2026
- Published by Elsevier in Journal of Voice
Practice Patterns of Speech-Language Pathologists for Vocal Fold Paresis
- 7 January 2026
- Published by Elsevier in Journal of Voice
Perceptions of the Effect of Habits on Vocal Health: Comparing Healthcare Providers to Vocalists
- 7 January 2026
- Published by Elsevier in Journal of Voice
Perceptions of the Effect of Habits on Vocal Health: Comparing Healthcare Providers to Vocalists
- Open Access
- 19 June 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (11) , 4614-4619
Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction: A Prospective Cohort Study
Objectives: Retrograde Cricopharyngeal Dysfunction (RCPD) is treated by botulinum toxin (BTX) injection into the cricopharyngeus. This prospective study compares the effectiveness and side effects of operating room (OR) and in‐office (IO) injections.Methods: Patients over 18 years of age with inability to burp, abdominal, thoracic, or cervical gurgling sounds, bloating, and excessive flatulence were diagnosed with RCPD and included in the study. Injections were performed in the OR (80U) or IO (30U) by the senior author. An RCPD questionnaire quantifying major and minor symptoms on a Likert scale, Eating Assessment Tool‐10 (EAT‐10), and Generalized Anxiety Score−7 (GAD‐7), were completed preinjection; at 1, 2, and 3 weeks; and 3 months postoperatively. Linear mixed models were used to analyze effects of BTX injection on RCPD symptoms, the EAT‐10, and the GAD‐7.Results: 108 (55 M/53F) patients completed the pretreatment survey, 53 (31 OR vs. 22 IO) completed the 3‐week follow‐up, and 36 (22 OR vs. 14 IO) completed the 3‐month questionnaire. Average posttreatment RCPD scores were significantly lower in both groups at 3 weeks and 3 months (p < 0.0001), There was no difference between IO or OR (p = 0.4924). GAD‐7 scores were significantly lower in both groups at week 3 (p = 0.0018) and month 3 (p = 0.0012). Postinjection EAT‐10 scores were significantly higher in OR compared with IO (p = 0.0379).Conclusion: OR and IO injections are equally effective in the treatment of RCPD. Postinjection dysphagia is more severe after the OR injections which may be related to higher doses of BTX used. General anxiety levels decrease with treatment.Level of Evidence: 2 Laryngoscope, 134:4614–4619, 2024
- 19 June 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (11) , 4614-4619
Open AccessBotulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction: A Prospective Cohort Study
Objectives: Retrograde Cricopharyngeal Dysfunction (RCPD) is treated by botulinum toxin (BTX) injection into the cricopharyngeus. This prospective study compares the effectiveness and side effects of operating room (OR) and in‐office (IO) injections.Methods: Patients over 18 years of age with inability to burp, abdominal, thoracic, or cervical gurgling sounds, bloating, and excessive flatulence were diagnosed with RCPD and included in the study. Injections were performed in the OR (80U) or IO (30U) by the senior author. An RCPD questionnaire quantifying major and minor symptoms on a Likert scale, Eating Assessment Tool‐10 (EAT‐10), and Generalized Anxiety Score−7 (GAD‐7), were completed preinjection; at 1, 2, and 3 weeks; and 3 months postoperatively. Linear mixed models were used to analyze effects of BTX injection on RCPD symptoms, the EAT‐10, and the GAD‐7.Results: 108 (55 M/53F) patients completed the pretreatment survey, 53 (31 OR vs. 22 IO) completed the 3‐week follow‐up, and 36 (22 OR vs. 14 IO) completed the 3‐month questionnaire. Average posttreatment RCPD scores were significantly lower in both groups at 3 weeks and 3 months (p < 0.0001), There was no difference between IO or OR (p = 0.4924). GAD‐7 scores were significantly lower in both groups at week 3 (p = 0.0018) and month 3 (p = 0.0012). Postinjection EAT‐10 scores were significantly higher in OR compared with IO (p = 0.0379).Conclusion: OR and IO injections are equally effective in the treatment of RCPD. Postinjection dysphagia is more severe after the OR injections which may be related to higher doses of BTX used. General anxiety levels decrease with treatment.Level of Evidence: 2 Laryngoscope, 134:4614–4619, 2024